The Asia Pacific antacids market is expected to reach US$ 3,255.05 million in 2027 from US$ 2,287.19 million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020-2027.
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate. The scope of the antacids market includes dosage form, drug class, distribution channel, and region.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC ANTACIDS MARKET SEGMENTATION
By Dosage Form
- Tablet
- Liquid
- Others
By Drug Class
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Magaldrate
- Sucralfate
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Dosage Form, Drug Class, Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market – By Dosage Form
1.3.2 Antacid Market – By Drug Class
1.3.3 Antacid Market – By Distribution Channel
1.3.4 Asia Pacific Antacid Market – By Country
2. Asia Pacific Antacid Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antacid Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antacid Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Innovative Product Launches by Market Players
5.1.2 Higher Incidence of the Obese Population
5.2 Market Restraints
5.2.1 Stringent Regulatory Norms and Several Challenges Associated with Gastrointestinal Diseases
5.3 Market Opportunities
5.3.1 Increasing Demand for OTC (Over the Counter) Antacid Medications
5.4 Future Trends
5.4.1 Rising Development of the Pharmaceutical Industry
5.5 Impact Analysis
6. Antacid Market – Asia Pacific Analysis
6.1 Asia Pacific Antacid Market Revenue Forecasts and Analysis
7. Asia Pacific Antacid Market Analysis and Forecasts to 2027 – By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8. Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.4 H? Antagonist
8.4.1 Overview
8.4.2 H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9. Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 Asia-Pacific: Antacid Market
10.1.1 Overview
10.1.2 Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
10.1.3 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.3.3.1 China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.4 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.4.3.1 Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.5 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.5.5 India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.6.3.1 South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.7 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.7.3.1 Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.8.3.1 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Antacid Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 2. China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 3. China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 4. China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 10. India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 12. India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 14. South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 18. Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 19. Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 23. Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms, Antacid Market
LIST OF FIGURES
Figure 1. Antacid Market Segmentation
Figure 2. Asia Pacific Antacid Market Overview
Figure 3. Tablet Segment Held Largest Share of Dosage Form in Antacid Market
Figure 4. Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market
Figure 5. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Antacid Market - Asia Pacific PEST Analysis
Figure 7. Antacid Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Antacid Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 10. Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 14. Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 21. Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Asia-Pacific: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
Figure 26. China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
Figure 27. Japan Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Australia: Antacid – Revenue and Forecast to 2027 (USD Million)
Figure 31. Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Antacids Market
Apr 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)